Publications by authors named "Robert W Naumann"
Ovarian cancer carries a lifetime risk of approximately 2% for women and is the leading cause of death from any gynecologic malignancy. Currently, no screening program for ovarian cancer exists for the general population in the UK. This review focuses on the evidence surrounding the efficacy of current markers and discusses future improvements in screening for this disease.
View Article and Find Full Text PDFArticle Synopsis
- The N.N. Alexandrov National Cancer Center of Belarus hosted an international conference focused on gynecologic and urologic oncology, partnering with the International Gynecologic Cancer Society and the U.S. National Cancer Institute.
- Experts shared updates on treatment advancements and local practices for managing gynecologic cancers in the Commonwealth of Independent States.
- The conference concluded with a resolution aimed at pinpointing improvement areas and fostering future collaboration in cancer treatment.
Introduction Tissue dissection and vessel sealing is performed using a variety of energy sources and surgical devices. We describe the postmarketing analysis of a cordless ultrasonic dissector and vessel sealer in a series of general and gynecological procedures. Methods Patients were prospectively screened and consented for participation.
View Article and Find Full Text PDFOvarian cancer is the fourth leading cause of gynecological cancer death among women in the United States. Early detection is a critical prerequisite to initiating effective cancer therapy. Gene microarray technology and proteomics have provided much of the biomarkers with potential use for diagnosis.
View Article and Find Full Text PDF